MedPath

A Research Study to Evaluate the Effects of Repeated Intravitreal Injections on Bacteria Around the Eye

Not Applicable
Conditions
Central Retinal Vein Occlusion
Choroidal Neovascularization
Age-related Macular Degeneration
Branch Retinal Vein Occlusion
Interventions
Procedure: Conj flora Antibiotic resistance
Registration Number
NCT01531842
Lead Sponsor
Mid Atlantic Retina
Brief Summary

This is a research study to evaluate the effects of repeated intravitreal injections on bacteria around the eye.

Detailed Description

The primary objective of this study is to determine whether conjunctival bacterial flora are altered and/or demonstrate increasing antibiotic resistance after serial intravitreal injections when a prophylactic topical antibiotic is used pre- and post-injection compared to when they are not used.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria

Subjects will be eligible if the following criteria are met:

  • Ability to provide written informed consent and comply with study assessments for the full duration of the study.
  • Have been diagnosed with neovascular AMD, CRVO or BRVO.
  • Have been determined by the investigator to require intravitreal injections of bevacizumab or ranibizumab.
Exclusion Criteria

Subjects meeting any of the following criteria are ineligible for study entry:

  • Prior intraocular injection in either eye.
  • Chronic use of opthalmic medication.
  • Contact lens wear.
  • Ocular surgery within the past 6 months.
  • Use of ophthalmic medications in either eye or ocular infection within the past 6 months.
  • Use of systemic antibiotics within 6 months.
  • Known allergy or contraindication to povidone iodine or fluoroquinolones.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Topical antibioticConj flora Antibiotic resistancePatients will be randomized in a 1:1 fashion to receive a drop of topical antibiotic before and after the intravitreal injection in the +ABX arm (in addition to the typical prep with betadine).
No Antibiotic ArmConj flora Antibiotic resistanceNo topical antibiotics in the -ABX arm (only the typical prep with betadine)
Primary Outcome Measures
NameTimeMethod
Determine if conj bacterial flora demonstrates increased antibiotic resistance if topical antibiotic used pre and post injection vs not used.Prior to each of your eye injections for the first 4 injections and continue through the completion of your fourth injection, an anticipated maximum of 6 months.

Evaluating the effects of repeated use of iodine drops with or without antibiotic eye drops on bacteria on the eye surface in patients undergoing injections in the eye to determine if conjunctival bacterial floar are altered or demonstate increasing antibiotic resistance.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Wills Eye Institute

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath